Table 2.
Variable | Number | pCR N (%) | p value |
---|---|---|---|
Gender | 0.986 | ||
Male | 207 | 55 (26.6) | |
Female | 90 | 24 (26.7) | |
Age& | 0.163 | ||
≤56 | 159 | 37 (23.3) | |
>56 | 138 | 42 (30.4) | |
Pre-Hb@ (g/L) | 0.348 | ||
Anemia | 55 | 12 (21.8) | |
Normal | 228 | 64 (28.1) | |
Pre-CEA (ng/mL) | <0.001 | ||
≤5.33 | 167 | 61 (36.5) | |
>5.33 | 130 | 18 (13.8) | |
Distance between lower border of tumor and anal verge (cm) | 0.464 | ||
≤5 | 172 | 43 (25.0) | |
>5 | 125 | 36 (28.8) | |
Histological grade | 0.74 | ||
G1 | 21 | 5 (23.8) | |
G2 | 238 | 62 (26.1) | |
G3 | 38 | 12 (31.6) | |
Clinical T | 0.011 | ||
T1-3 | 122 | 42 (34.4) | |
T4 | 175 | 37 (21.1) | |
Clinical N | 0.886 | ||
N0 | 92 | 23 (25.0) | |
N+ | 205 | 56 (27.3) | |
Clinical stage | 0.579 | ||
II | 90 | 22 (24.4) | |
III | 207 | 57 (27.5) | |
Interval between completion neo-CRTand surgery (week) | 0.658 | ||
≤4 | 8 | 1 (12.5%) | |
4~8 | 237 | 64 (27.0%) | |
≥8 | 52 | 14 (26.9%) |
@: grouped by whether anemia, male normal 120g/L, female normal 110g/L; &: grouped by median